BioCentury
ARTICLE | Company News

Anthem to cover Veracyte's Afirma test for detecting thyroid cancer

June 2, 2017 3:00 PM UTC

Veracyte Inc. (NASDAQ:VCYT) said Anthem Inc. (NYSE:ANTM) issued a positive coverage decision for Afirma Gene Expression Classifier for thyroid cancer diagnosis. Afirma is a preoperative molecular di...

BCIQ Company Profiles

Anthem Inc.

Veracyte Inc.